Company

Protagonist Therapeutics, Inc (PTGX)

Standardized SEC financial data for Protagonist Therapeutics, Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001377121 · NASDAQ · Pharmaceutical Preparations.

Operating margin

-343.6%

Net margin

-282.8%

Revenue growth (YoY)

-89.4%

Return on equity

-21.2%

ROIC

-25.2%

Free cash flow

$56.1M

Debt / equity

0.02×

Current ratio

12.71×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$28.6M	$27.4M	$26.6M	$60.0M	$434.4M	$46.0M
R&D expense	$74.5M	$126.0M	$126.2M	$120.2M	$138.1M	$159.3M
SG&A expense	$18.6M	$27.2M	$31.7M	$33.5M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$117.8M	$123.9M	$126.0M	$187.0M	$97.5M	$128.7M
Total current assets	$315.6M	$340.7M	$243.1M	$355.6M	$591.6M	$577.6M
Property, plant & equipment	$1.5M	$1.8M	$1.6M	$1.2M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$72.5M	-$107.9M	-$108.1M	-$70.2M	$184.2M	$57.7M
Capital expenditures	$471K	$1.1M	$795K	$609K	$1.4M	$1.6M
Free cash flow	-$73.0M	-$109.0M	-$108.9M	-$70.8M

Get PTGX data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PTGX/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PTGX/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View PTGX filings on SEC EDGAR →